Funding for Luxturna following MSAC recommendation
Luxturna has become the first gene therapy to receive government funding in Australia, in a landmark decision that will see ...
Tag: pathological biallelic RPE65
Luxturna has become the first gene therapy to receive government funding in Australia, in a landmark decision that will see ...